News
The government provides significant new funding to Genomic Medicine Sweden to strengthen precision medicine
The Swedish government announces that it will fund Genomic Medicine Sweden (GMS) with SEK 80 million in 2025. The money will go to continued efforts to develop and sustainably implement precision medicine in healthcare in the areas of cancer, rare diseases and...
Sweden contributes to the EU project Beyond One Million Genome plus
The comprehensive EU project Beyond One Million Genome plus (B1MGplus) has officially started. The new project, funded by the European Commission under the Digital Europe Programme, coordinates and supports the 1+ Million Genomes’ initiative to enable secure access to...
Cross-border collaboration accelerates diagnosis of rare diseases
Living with an undiagnosed disease poses great challenges for both individuals and families. Through initiatives like UDN Sweden and the world’s first Undiagnosed Hackathon for undiagnosed rare diseases, national and international expertise is coming together to...
Genomic Medicine Sweden and the Danish National Genome Center strengthen collaboration in personalised medicine
Genomic Medicine Sweden (GMS) and the Danish National Genome Center (DNGC) have renewed their memorandum of understanding to promote the development of personalised medicine in Sweden and Denmark. The strategic collaboration aims to improve the conditions for...
Complex diagnoses can be solved with new technology
Using a new technique, long-read sequencing, that allows DNA to be analyzed in much greater detail than before, a team of Swedish clinicians and researchers has discovered an unexpected complexity in chromosomal abnormalities. The study opens the door to more precise...
New gene panel improves blood cancer diagnostics
Accurate identification of disease-causing genetic alterations is crucial for refining the diagnosis and treatment of blood cancers. The broad gene panel for myeloid malignancies, a subset of blood cancers, developed by Genomic Medicine Sweden in collaboration with...
Cost of whole-genome sequencing approaching current routine genetic testing in blood cancer
The cost of whole-genome sequencing is approaching that of the traditional genetic tests currently used for patients diagnosed with acute leukemia, according to a new study published in the Journal of Medical Economics. With costs falling and whole-genome sequencing...
Leading experts join the GMS Informatics Advisory Board
The national steering group of Genomic Medicine Sweden (GMS) has appointed Samuli Ripatti, Jayne Hehir-Kwa, Christian Gilissen, Augusto Rendon, Tony Håndstad and Mathias Ekman as members of the new GMS Informatics Advisory Board. “We are delighted to welcome this...